Galenus is live (Follow the great medical teacher)
Update: Galenus is live on Kickstarter, in a joint campaign with Bios: Mesofauna. You may pledge for a copy of the game or get it together with Mesofauna.
Our preview post below was published on October 16.
Galenus is a 1-4 player worker placement game in which you play as a young doctor in ancient Rome trying to impress Galenus, the Greek medical authority. The game will launch on Kickstarter on October 20, along with Bios:Mesofauna.
Your goal in Galenus is to cure patients, publish your work, and win medical contests so that you gather the most victory points. Each player board has tracks for Philosophy, Fame, Health and Focus that interact with each other. This means that if, for example, you reach maximum Fame, you will then lose a Health point as popularity in ancient Rome caused your enemies to poison you.
You have six pawns available to use in both the Planning and the Action phase. On each turn, you may place a pawn in any of the locations on the board: the gladiator arena, the medical theatre, the Thermae, the Asclepeion, the Gymnasium, Lemnos, or the Home spot on the player's board. After the placement, you move your pawn on the 'Getting results' space of the location you chose. When you get results, you can start healing patients. At first you can only cure a few but as you increase your learning, the number of patients you treat will increase as well.
When you cure a patient, you increase your skill in the associated disease (the 'humours' as they were called in antiquity) but you need to also have published works in order to make further progress. In the Medical Contest phase, players do an auction that earns them fame.
In the solo mode, you play as the young Galenus in his home city of Pergamon, before he gained fame and settled in Rome. Gameplay is almost similar to the multiplayer mode but also adds "Perga" and "Mon" cards that give the player objectives to fulfill, as well as the Challengers: the teachers of Galenus who remove cubes/cards from the board.
Comments